Reports for RISPERIDONE
Ingredient
RISPERIDONE
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
PMS-RISPERIDONE | 0.25MG | TABLET | Resolved | 2017-09-08 | 2017-11-17 | 21712 |
PMS-RISPERIDONE | 0.25MG | TABLET | Resolved | 2017-10-27 | 2017-12-15 | 27354 |
TEVA-RISPERIDONE | 0.25MG | TABLET | Resolved | 2020-06-04 | 2020-07-09 | 116672 |
TEVA-RISPERIDONE | 0.25MG | TABLET | Resolved | 2021-05-20 | 2021-07-22 | 139749 |
TEVA-RISPERIDONE | 0.25MG | TABLET | Resolved | 2022-06-16 | 2022-09-08 | 162861 |
APO-RISPERIDONE | 0.25MG | TABLET | Resolved | 2017-03-17 | 2017-06-01 | 3183 |
APO-RISPERIDONE | 0.25MG | TABLET | Resolved | 2017-08-23 | 2017-11-29 | 20122 |
APO-RISPERIDONE | 0.25MG | TABLET | Resolved | 2017-08-31 | 2017-11-30 | 20707 |
APO-RISPERIDONE | 0.25MG | TABLET | Resolved | 2020-08-06 | 2020-11-09 | 121913 |
APO-RISPERIDONE | 0.25MG | TABLET | Resolved | 2022-07-29 | 2022-10-31 | 165674 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
RISPERDAL | 0.25MG | TABLET | Discontinued | 2018-11-29 | 2019-04-02 | 68095 |
MYLAN-RISPERIDONE | 0.25MG | TABLET | Discontinued | 2017-07-18 | 2018-02-15 | 16154 |
MYLAN-RISPERIDONE | 0.50MG | TABLET | Discontinued | 2017-07-18 | 2018-02-15 | 16157 |
RISPERDAL | 0.5MG | TABLET | Discontinued | 2018-11-29 | 2019-04-02 | 68098 |
MYLAN-RISPERIDONE ODT | 0.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149759 |
SANDOZ RISPERIDONE | 1.0MG | TABLET | Discontinued | 2021-08-19 | 2021-08-19 | 144338 |
MYLAN-RISPERIDONE | 1.0MG | TABLET | Discontinued | 2017-07-18 | 2017-09-08 | 16160 |
RISPERDAL | 1MG | TABLET | Discontinued | 2018-11-29 | 2019-04-02 | 68085 |
RISPERDAL ORAL SOLUTION | 1MG | SOLUTION | To be discontinued | 2023-04-27 | 2023-04-27 | 190894 |
PMS-RISPERIDONE ODT | 1MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-06-17 | 2020-06-17 | 118150 |